Kenneth I. Moch

Insider Reports History

Entity
Individual
Location
68 Willow Ave, Larchmont, NY
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth I. Moch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gamida Cell Ltd. Director Ordinary Shares 232K Jan 31, 2024 Direct
Gamida Cell Ltd. Director Share Option (Right to Buy) 56.6K Oct 19, 2023 Direct
Zynerba Pharmaceuticals, Inc. Director Common Stock 0 $1.33 Oct 10, 2023 Direct
Zynerba Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 Oct 10, 2023 Direct

Insider Reports Filed by Kenneth I. Moch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GMDA Gamida Cell Ltd. Jan 31, 2024 1 $0 4 Feb 2, 2024 Director
GMDA Gamida Cell Ltd. Oct 19, 2023 2 $0 4/A Oct 20, 2023 Director
ZYNE Zynerba Pharmaceuticals, Inc. Oct 10, 2023 4 $0 4 Oct 11, 2023 Director
ZYNE Zynerba Pharmaceuticals, Inc. Jun 13, 2023 3 -$40 4 Jun 15, 2023 Director
GMDA Gamida Cell Ltd. Feb 8, 2023 2 $0 4 Feb 10, 2023 Director
GMDA Gamida Cell Ltd. Nov 18, 2022 2 $0 4 Nov 22, 2022 Director
ZYNE Zynerba Pharmaceuticals, Inc. Jun 14, 2022 3 -$40 4 Jun 16, 2022 Director
GMDA Gamida Cell Ltd. Jan 1, 2022 0 $0 3 Jan 3, 2022 Director
ZYNE Zynerba Pharmaceuticals, Inc. Aug 3, 2021 2 $0 4 Aug 5, 2021 Director